Skip to content

Stasis Dermatitis

Basics

  • Chronic eczematous, scaling, erythematous plaques/patches on lower legs.
  • Associated with chronic venous insufficiency (valve dysfunction/reflux or vein obstruction).
  • Typical location: medial ankle, can extend to foot and lower leg.
  • May present as solitary lesion; often bilateral.
  • Can be accompanied by venous leg ulcers on bony prominences.

Epidemiology

  • Common in patients >50 years (6-7% incidence in the US).
  • Female predominance.
  • Estimated 15-20 million affected in US aged >50.

Etiology and Pathophysiology

  • Venous hypertension from venous valve incompetence or obstruction.
  • Microvascular changes: leaking capillaries, fibrin cuffs, thickened venules, microthrombosis.
  • Chronic dependent edema inflames skin, predisposing to trauma and pruritus.
  • Itch mediated by inflammatory cells and endothelial dysfunction.
  • Familial predisposition likely.

Risk Factors

  • Atopy, chronic edema.
  • Old age, obesity.
  • Smoking.
  • Previous DVT, pregnancy, vein stripping/harvesting.
  • Prolonged standing.
  • Trauma.
  • Low-protein diet.
  • High estrogen states.
  • Genetic/familial congenital vein disease.

General Prevention

  • Treat edema via leg elevation, compression stockings, exercise.
  • Early venous insufficiency management by specialists.
  • Use emollients twice daily to prevent fissures and itching.

Commonly Associated Conditions

  • Varicose veins, venous insufficiency.
  • Hyperhomocysteinemia.
  • Venous hypertension.

Diagnosis

History

  • Itching, pain, burning precede rash.
  • Bilateral lower extremity edema and aching/heaviness.
  • Erythema and scaling with hyperpigmentation.
  • Symptoms worsen with prolonged dependency.

Physical Exam

  • Bilateral scaly, eczematous patches, papules, plaques.
  • Violaceous/brown erythema from hemosiderin.
  • Medial ankle distribution, possible foot/lateral ankle extension.
  • Superficial veins visible, pitting edema.
  • Brawny induration, warmth.
  • Venous ulcers over bony prominences.
  • Later excoriations, weeping, crusting.
  • Possible comorbid atrophie blanche, lipodermatosclerosis.
  • Contact sensitization and autosensitization dermatitis possible.

Differential Diagnosis

  • Atopic, uremic, contact dermatitis.
  • Neurodermatitis.
  • Arterial insufficiency.
  • Sickle cell ulcers.
  • Cellulitis, erysipelas.
  • Tinea, pretibial myxedema.
  • Nummular eczema.
  • Lichen simplex chronicus.
  • Xerosis, asteatotic eczema.
  • Amyopathic dermatomyositis.
  • Psoriasis.
  • Actinic keratoses.
  • Skin cancers.

Diagnostic Tests

  • Duplex ultrasound: confirms venous insufficiency (reflux duration >0.5 sec superficial/perforating veins, >1 sec deep veins).
  • Cross-sectional venography (CT/MR) if ultrasound equivocal.
  • Skin biopsy for uncertain cases (cautiously due to arterial insufficiency risk).
  • Rule out arterial insufficiency: check pulses, ankle-brachial index (ABI).
  • Screen for diabetes.
  • Catheter venography before interventions.

Treatment

General Measures

  • Reverse venous hypertension:
  • Leg elevation (30 min, 3-4 times daily).
  • Compression therapy (bandages, stockings) if ABI 0.8-1.2.
  • Graduated compression (30-40 mm Hg) improves healing/prevents ulcers.
  • Pneumatic compression devices for nonambulatory or mixed arterial cases.
  • Encourage regular exercise, avoid prolonged standing.
  • Inpatient/endovascular interventions for severe cases (radiofrequency ablation, vein stripping, sclerotherapy, skin grafts).
  • Venous ulcer care:
  • Debride necrotic tissue.
  • Use moist wound dressings (hydrogel, hydrocolloid, foam).
  • Granulocyte-macrophage colony-stimulating factor may aid healing.
  • Surgical correction of venous hypertension if indicated.

Medication

  • Pentoxifylline 400 mg TID: effective for venous leg ulcers.
  • Antibiotics only for clinical infection (cellulitis, pain, malodor).
  • Oral antibiotics for secondary infections: dicloxacillin, cephalexin, levofloxacin.
  • MRSA: clindamycin, doxycycline, TMP/SMX, vancomycin.
  • No evidence for routine antiseptics.
  • Short courses topical steroids (triamcinolone 0.1% BID) for dermatitis.
  • Topical antipruritics: pramoxine, camphor, menthol, doxepin.
  • Lidocaine/prilocaine for pain during debridement.
  • Silver sulfadiazine for wound healing.
  • Topical emollients and antihistamines (diphenhydramine, cetirizine) for chronic cases.
  • Hydrocolloid or foam dressings may reduce pain.

Second Line

  • Antibiotics guided by culture.
  • Lubricants for quiescent dermatitis.

Issues for Referral

  • Nonhealing ulcers.
  • Arterial insufficiency.
  • Patch testing for contact dermatitis.
  • Varicose veins and venous insufficiency.

Additional Therapies

  • Discontinue meds causing edema if possible (amlodipine, gabapentin).

Surgery/Other Procedures

  • Sclerotherapy, ablation, vein stripping, skin grafting for venous disease.

Ongoing Care

Follow-up

  • Reapply Unna boots weekly.
  • Regular compression stockings use to prevent ulcer recurrence.

Diet

  • Weight loss if overweight.

Patient Education

  • Encourage activity and leg elevation.
  • Avoid constrictive garments.
  • Apply compression stockings before getting up.
  • Do not scratch affected areas.

Prognosis

  • Chronic intermittent exacerbations/remissions.
  • Ulcer healing prolonged (months).
  • Quality of life impacted by itching, pain, burning.

Complications

  • Secondary bacterial infection.
  • Contact sensitization/auto-sensitization dermatitis.
  • Bleeding from dermatitis sites.
  • Squamous cell carcinoma at long-standing ulcer edges.
  • Scarring compromising circulation.

ICD10 Codes:
- I83.10 Varicose veins of unspecified lower extremity with inflammation
- I83.11 Varicose veins of right lower extremity with inflammation
- I83.12 Varicose veins of left lower extremity with inflammation


Clinical Pearls:
- Edema treatment via elevation, exercise, compression essential.
- Hydrocolloid vs nonadherent dressing under compression shows no difference in healing rate.
- Dressing choice should consider cost and preference.